Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eton Pharmaceuticals (ETON) Equity Ratio (2017 - 2025)

Eton Pharmaceuticals' Equity Ratio history spans 8 years, with the latest figure at 0.28 for Q4 2025.

  • On a quarterly basis, Equity Ratio fell 11.52% to 0.28 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.28, a 11.52% decrease, with the full-year FY2025 number at 0.28, down 11.52% from a year prior.
  • Equity Ratio hit 0.28 in Q4 2025 for Eton Pharmaceuticals, up from 0.22 in the prior quarter.
  • Over the last five years, Equity Ratio for ETON hit a ceiling of 0.69 in Q2 2021 and a floor of 0.22 in Q3 2025.
  • Historically, Equity Ratio has averaged 0.48 across 5 years, with a median of 0.51 in 2022.
  • Biggest five-year swings in Equity Ratio: soared 383.21% in 2021 and later plummeted 50.37% in 2025.
  • Tracing ETON's Equity Ratio over 5 years: stood at 0.64 in 2021, then decreased by 18.6% to 0.52 in 2022, then fell by 6.67% to 0.49 in 2023, then plummeted by 34.19% to 0.32 in 2024, then dropped by 11.52% to 0.28 in 2025.
  • Business Quant data shows Equity Ratio for ETON at 0.28 in Q4 2025, 0.22 in Q3 2025, and 0.24 in Q2 2025.